Form 4: Immix Biopharma CFO Gabriel Morris Acquires 3,300 Shares
SEC Form 4 Filing
CFO of Immix Biopharma, Gabriel Morris, reports the acquisition of 3,300 shares of common stock at $1.8099 per share.
Summary
- On June 4, 2024, Gabriel Morris, CFO of Immix Biopharma, acquired 3,300 shares of common stock at a price of $1.8099 per share.
- Following the transaction, Morris directly owns 283,334 shares of Immix Biopharma.
- Morris also indirectly owns 270,844 shares through Alwaysraise LLC and 24,141 shares through Alwaysraise Ventures I, LP.
- Morris disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment. It simply reports a transaction.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of transaction: Gabriel Morris acquired 3,300 shares of Immix Biopharma common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.